Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705132 · ClinicalTrials.gov registry record
Urinary Biomarkers of the Progression of Alport Kidney Disease
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 80
- Enrollment target
NCT01705132 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 80 participants.
The verdict
NCT01705132 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if there are certain laboratory tests that can be performed to detect substances or features in a child's urine that can be used to measure the progress of Alport kidney disease and the effects of treatment. These tests and their results could be of use to measure responses to new treatments in future clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01705132
The ClinicalTrials.gov registry entry for NCT01705132 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01705132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01705132 about?
NCT01705132 is a clinical study titled "Urinary Biomarkers of the Progression of Alport Kidney Disease". The purpose of the study is to determine if there are certain laboratory tests that can be performed to detect substances or features in a child's urine that can be used to measure the progress of Alport kidney disease and the effects of treatment. These tests and their results could be of use to me...
What is the current status of trial NCT01705132?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2012-06. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01705132?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.